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Limb girdle muscular dystrophy type 2B is a rare subtype of muscular dystrophy, the predominant feature of which
is muscle weakness. The disease is caused by an autosomal recessively inherited reduction/absence of muscle
dysferlin due to a mutation in dysferlin gene at 2p12-14. We report a 10 year old boy who presented with severe
non-transient right knee pain and swelling, which later became bilateral. His pain was worst in the morning and
during rest. Blood tests revealed markedly raised creatine kinase values (highest 22, 297 U/l), raising the possibility
of an inflammatory myositis. MRI showed bilateral asymmetrical muscle involvement of thighs and calves with
oedematous changes mimicking the imaging appearances of inflammatory myositis. CRP and ESR levels were
consistently within normal limits. Over several months his knee pain worsened and limited walking. Muscle biopsy
revealed a severe reduction of dysferlin immunostaining, indicating the diagnosis, which was confirmed by 2
compound heterozygous pathogenic mutations in the dysferlin gene. It is not unusual for this subtype of the
disease to mimic myositis: however, significant pain is a rare presenting symptom. Given the significant overlap
between this form of muscular dystrophy and inflammatory myopathies, a high index of suspicion is needed to
ensure an accurate and timely diagnosis. Furthermore, characteristic inflammatory-related morning pain should not
rule out consideration of non-inflammatory causes.
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Muscle pain is a common presenting symptom to paediat-
ric rheumatology clinics. The overlap between differential
diagnoses can sometimes make such cases challenging.
Limb girdle muscular dystrophies (LGMD) are a rare
group of conditions, the predominant feature of which is
weakness of lower and upper limbs, although symptoms
may predominate in one muscle group. The typical pre-
senting symptom is difficulty climbing stairs. LGMD type
2B is an autosomal recessive condition due to homozygous
or compound heterozygous mutations in the dysferlin gene
(DYSF) on 2p12-14, leading to a deficiency or absence of
the protein, dysferlin. This protein is primarily found in
skeletal muscle but can also be found in cardiac muscle
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reproduction in any medium, provided the ortypically presenting with pelvic girdle weakness [2]. Pain is
not a typical feature however, if present, is usually mild,
transient and follows exertion. Creatine kinase (CK)
levels are markedly raised and can be 10–72 times nor-
mal values [1-3]. At times, genetically inherited myop-
athies can mimic inflammatory myopathy. Pimentel
et al. (2008) describe an adult case of LGMD type 2
subject to misdiagnosis of polymyositis, despite having
consanguinous parents and also two siblings with similar
symptoms of muscle weakness [4].
Although disease caused by a reduction/absence in
dysferlin typically demonstrates a slow indolent course [5],
in some cases symptoms may be highly debilitating [3].
Nyugen et al. (2007) describe a patient with a dysferlinopathy
who had complete loss of ambulation just five years after
symptom onset [5]. Given the wide spectrum of disease se-
verity with dysferlinopathies, it is vital that healthcare profes-
sionals are aware of atypical presentations of the condition.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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diagnosis to ensure adequate and timely treatment in order
to help minimize progression.
Here we report an atypical case of LGMD type 2B pre-
senting at the age of ten years with significant, non-
transient knee pain which was worst in the morning.
Case presentation
The patient was a boy of West African origin born to non-
consanguineous parents who presented aged 10 years with
a one year history of bilateral knee pain, radiating down the
legs. The pain started in the right knee after a long
walk, was of fairly rapid onset, and was associated
with swelling. Within a few weeks, his left knee subse-
quently also became painful and swollen. The pain was very
localised to the knee and was continuous but with intermit-
tent exacerbations, being worse in the mornings and during
rest.
Non-steroidal anti-inflammatory medication pre-
scribed by his general practitioner provided only mild
symptomatic relief. Two months after symptom onset,
he was reviewed by his paediatrician. Investigations
demonstrated ESR and CRP values were within normal
limits (5 mm/hr and 4 mg/L, respectively), as was the
ACE level. He was negative for sickle cell trait. Knee
MRI scan showed a small joint effusion and no synovial
thickening. Aspiration and culture of synovial fluid was
negative and remarkably noted as being almost acellular.
Around this time a dark, ecchymosis-like rash around
the affected knee developed, which was possibly second-
ary to warm compresses. The general paediatric team
prescribed intramuscular Depo-Medrone 80mg, which
only provided 5–6 days of relief. Over the following 9
months the patient was readmitted several more times
with severe pain. He had no other rash, no high fe-
vers, no eye problems other than an episode of con-
junctivitis a month prior to the onset of pain. He had
no ulcers, no alopecia, no profound fatigue, no sore-
ness of the mouth, no breathlessness and no change
in bowel habit.
He was an only child, born by a normal vaginal deliv-
ery at 42 weeks gestation. Both parents have sickle cell
trait. There was no family history of autoimmune dis-
ease and no relevant past medical history.
On examination during his first Paediatric rheumatology
appointment, he was on the 99th and 98th centile for his
weight and height, respectively. He was afebrile with no
mouth ulcers, nail fold abnormalities and no lymphadenop-
athy. Cardiovascular and respiratory examinations were un-
remarkable. He had a small right knee effusion with some
pain on flexion. The knee was held in a few degrees of
flexion, although it was possible to get the knee to neutral.
One month later, he was admitted to hospital follow-
ing worsening of his knee pain. At this point he reportedincreasing difficulty standing up and needed help getting
dressed and getting into the bath due to lower limb
muscle weakness. On examination calf and thigh hyper-
trophy was noted bilaterally, the latter being more pro-
minent. He had good strength (5/5) in his neck, upper
limb, abdominal and shoulder muscles. Accurate assess-
ment of strength was difficult because of pain and cooper-
ation; he appeared weak in the lower limbs with 3/5 power
in his quadriceps, however timed rise from floor sitting
position was 1.03 seconds and timed rise from lying was
1.5 seconds (both without a Gower's manoeuvre), both of
which were within the normal range.
He had tight long flexors of his arms, hamstrings and
gastrocnemius, but no swelling or restriction of his joints.
Hyperpigmented patches were noted over the right knee
and right thigh, but no rashes were seen; again this was
thought to possibly be secondary to warm compression.
During neuromuscular examination right lower limb as-
sessment was limited by significant right knee pain and he
was agitated due to pain. He was able to stand on his left
leg but was incapable of maintaining his balance. He had
good axial flexure strength in the antigravity range. Cranial
nerve examination was normal, with no facial weakness.
Over the next few months his pain became progressively
worse, with the pain awakening him during the night and
causing him to miss days off school.
Blood results revealed a raised ALT (145 U/l), in the
absence of liver disease. Muscle origin of this elevated
transaminase was considered and serum CK was
performed. CK was markedly elevated at 13,126 U/l,
with an LDH 2,245 U/l. ESR and CRP were normal.
ANA was negative. Muscle ultrasound scan of quadri-
ceps femoris was normal. Leg muscle MRI revealed mildly
reduced posterior compartment muscle bulk bilaterally
with bilateral asymmetrical oedematous changes within se-
lective thigh and calf muscles. Signal hyperintensity was
seen on the fat suppressed STIR (short tau inversion
recovery) images within the right sartorius muscle
and medial heads of gastrocnemius extending beyond
the anatomical boundary of the muscles into the adja-
cent fascia. Similar changes of muscle oedema were
seen within the left biceps femoris and right soleus
muscle (Figures 1 and 2). These changes are similar
to the imaging appearances of inflammatory condi-
tions such as dermatomyositis, but in an atypical
distribution.
Muscle biopsy revealed increased variation in fibres size
(8 to 52 micrometres, approximate normal for age
31–39) due a mixture of large fibres and small
rounded fibres. There were several basophilic fibres,
likely to be regenerating. There was a necrotic fibre
infiltrated by inflammatory cells and a few foci of
perimysial and endomysial chronic inflammatory cells
(Figure 3). There were a few internal nuclei but these
Figure 1 Axial STIR (top) and T1W (below) images of the thigh muscles just above the knee showing bilateral asymmetrical muscle
involvement. The right sartorius muscle (thin arrow) shows signal hyperintensity on the STIR images and some swelling consistent with oedema.
Signal hyperintensity extends just beyond the anatomical margins of the muscles into the adjacent fascia. Signal changes on the T1W images are
consistent with fatty infiltration. Similar changes are seen in the insertion of the left long head of biceps femoris (thick arrow). The remainder of
the posterior compartment muscles are slightly small.
Figure 2 Axial STIR (top, though with incomplete fat suppression) and axial T1W images through the calves showing various changes.
There are changes within the medial heads of both gastrocnemius muscles (short thick arrows) consistent with oedema, again with extension
beyond the anatomical boundary of the muscle into the adjacent fascia. There are also some milder diffuse oedematous changes within the right
soleus (thin arrow) and medial gastrocnemius muscles. No abnormal fatty changes were seen.
Jethwa et al. Pediatric Rheumatology 2013, 11:19 Page 3 of 6
http://www.ped-rheum.com/content/11/1/19
Figure 3 Histology of the muscle biopsy. Histology showed foci of necrotic fibres infiltrated by inflammatory cells (A, H&E); basophilic cells
reminiscent of regeneration (B, H&E); almost complete loss of dysferlin reactivity (C) with maintained caveolin-3 reactivity (D).
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gen deposition.
Immunohistochemistry for dysferlin was negative on
most fibres. A few fibres showed focal membranous stain-
ing. Internal staining for dysferlin was not seen. An exten-
sive panel of other dystrophy-related proteins was normal
(including dystrophin, sarcoglycans, alpha-dystroglycan,
merosin, emerin, collagen VI, desmin). There was some
sarcolemmal staining for utrophin. There was minimal
focal membrane staining for MHC class I and no stainingTable 1 Comparison of idiopathic inflammatory myopathies a
Idiopathic inflammatory myopathies [9]
Clinical
characteristics
Systemic symptoms and arthritis are common; rash.
Systemic symptoms and arthritis are common.
Onset often acute or subacute.
Pattern of
weakness
Proximal, but neck flexor and abdominal weakness
is a common early feature




Proximal muscle inflammation with high signal on
T2 weighted STIR images [10]
Typical muscle
biopsy features
MHC – class 1 upregulation, inflammatory infiltrate
(frequently peri-vascular), peri-fascicular muscle fibre
atrophy and endothelial cell abnormalities [11]
Genetics Polygenic trait
* Muscular dystrophies are genetically and phenotypically very heterogeneous, butof capillaries with Membrane Attack Complex (MAC). A
few fibres expressed developmental myosin.
A provisional diagnosis of LGMD type 2B was made
and was subsequently confirmed on dysferlin muscle im-
munoblotting and gene sequencing, which revealed two
heterozygous mutations in the DYSF gene (c.265C > T;
p.Arg89X in exon 4 and c.4756C > T; p.ARG1586X in
exon 43). Parental DYSF studies confirmed inheritance of
one of these mutations from each parent. The clinical
course over a 4 month follow up period showed waxingnd muscular dystrophies
Muscular dystrophies *
Selective patterns of muscle hypertrophy or atrophy,
with longstanding insidious onset of motor functional difficulties
Usually limb girdle or rarely axial or distal weakness depending on
muscular dystrophy subtype
Extremely high CK, often above 5,000 units
Typically specific patterns of muscle involvement with abnormal
signal on T1 weighted images in different muscular dystrophies
Dystrophic features (fibre necrosis, regeneration, fibrosis and fat
infiltration) with absence or reduction of specific protein/enzyme,
depending on specific muscular dystrophy subtype.
Autosomal dominant, recessive or X-linked inheritance
with multiple subtypes; this table generalises the muscular dystrophy features.
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course of oral prednisolone treatment. The mainstay of
symptom control included regular non-steroidal analge-
sics and management by the pain control team.
Discussion
A central feature of the presentation in this case was
muscle pain. Severe muscle pain is not typically a predom-
inant symptom of LGMD. However, of the different types,
LGMD type 2I is most closely associated with this feature
[6]. Although patients with other subtypes (eg. LGMD
type 2I, dystrophinopathies and facioscapulohumeral mus-
cular dystrophy) can also present with leg pain, this is usu-
ally mild and following exertion. The aetiology of pain
may be inflammatory or metabolic, and is thought to be
related to hypertrophy or pseudohypertrophy of the calf
muscles. Calf muscle atrophy, rather than hypertrophy, is
a major feature of LGMD type 2B and pain does not
typically predominate [7].
No case reports of LGMD type 2B to date describe
muscle pain as a central feature. Diers et al. (2007), how-
ever, describe a patient with an unusual phenotype, with a
novel compound heterozygous mutation in the Dysferlin
gene and, interestingly, painful hypertrophy in calf muscles
[2]. Calf swelling at onset of dysferlinopathies, however, is
rare and may lead to misdiagnosis of thrombophlebitis or
focal myositis [5]. Our case describes a patient with joint
and muscle pain, with mild calf and thigh muscle hyper-
trophy. Furthermore, the pain was extremely severe, non-
transient and was also present as morning pain, rather than
simply pain after exertion, perplexingly suggesting an in-
flammatory cause. The misdiagnosis of LGMD type 2B
as an inflammatory myopathy is not uncommon, es-
pecially when CK values are markedly raised [8]. This
case shows MR imaging changes of muscle and
perimuscular oedema similar to inflammatory condi-
tions such as dermatomyositis. Nyugen et al. (2007) re-
port 25% of their patients with dysferlinopathies having
been misdiagnosed with polymyositis due to histological
inflammatory muscle infiltrates associated with rapid
progression, with or without pain [5]. A table comparing
features of idiopathic inflammatory myopathies from
muscular dystrophies is shown in Table 1.
Dysferlin deficiency on muscle immunostaining is the
most pertinent feature for diagnosis of dysferlinopathies
and the final confirmation is with genetic analysis of
DYSF [12]. However, loss of dysferlin staining is well
recognised secondary phenomena in other limb girdle
muscular dystrophies, most well characterised in muta-
tions in caveolin-3 (LGMD 1C). Sequencing of this gene
is challenging as it contains 55 coding exons, spans
150kb of genomic DNA [12] and mutational hotspots do
not appear to exist [12,13].Conclusion
Our case describes an atypical case of LGMD type 2B,
with extremely elevated CK levels and severe pain and
swelling of a single knee joint, and MR imaging changes
initially suggestive of an inflammatory myopathy with a
monoarthritis. This report supports the need for a high
index of suspicion for muscular dystrophies in order to
provide an early diagnosis, initiate appropriate medical
care in a timely fashion and to avoid unnecessary im-
munosuppression for a presumed diagnosis of inflamma-
tory myopathy.
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